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Neuroaspergillosis usually manifests in immunocompromised patients. Here we present a case report of neuroaspergillosis in
an immunocompetent host after postoperative radiotherapy for squamous cell carcinoma of temporal bone.
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Introduction
Neuroaspergillosis is a very rare clinical entity but is
concerned as a serious disease, mostly presenting in
immunocompromised patients or patients with diabetes,
tuberculosis or after intracranial or skull base surgery [1-3].
An infection caused by Aspergillus fumigatus usually
extents intracranially directly from paranasal sinuses or
disseminates hematogenously from distant foci, e.g.
lung[4]. Despite adequate treatment, the prognosis is very
poor with a mortality approaching 100% in
immunocompromised patients [5]. In the presented case,
neuroaspergillosis developed in an immunocompetent
host with a history of surgery and fractionated
radiotherapy for squamous cell carcinoma (SCC) of the
temporal bone. We hypothesize that post-surgical defect of
the lateral skull base exposed to irradiation played a major
role in the pathogenesis of the invasive aspergillosis. The
preventing therapeutic possibilities are hypothesized in the
article. 
Case Report
A previously healthy 67 years old woman was referred to
our centre in June 2006 with progressive right-sided
hearing loss and otorrhoea. Otomicroscopic examination
revealed an obstructive bulging of the posterior wall of the
right external auditory canal. Histopathological
examination confirmed the diagnosis of SCC. Computed
tomography (CT) scanning showed no evident signs of
bone destruction (Figure 1), the soft tissues of middle ear
were involved, without convincing sign of the
involvement of medial wall, but with possible soft tissue
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involvement in the hypotympanum. Ultrasonographic
evaluation of the neck and chest radiography revealed no
regional or distant metastatic disease. According to the
modified system of the , the tumour was preoperatively
staged as cT3-4N0M0 [6, 7]. The patient underwent a lateral
temporal bone resection. Peroperatively, bone
involvement in antrum and hypotympanum was obvious,
but the tumour was resected completely, and the frozen
sections showed negative lateral margins. The tumour was
postoperatively staged as pT4N0M0. Because of the stage
of the tumour, the patient underwent adjuvant fractionated
radiotherapy with a total dose of 66 Gy.  
Despite regular intensive follow-up, one year
postoperatively she developed a right-sided facial
palsy (House-Brackmann grade VI), and severe
otalgia. Otoscopy revealed a cavity filled with multiple
fungal hyphae and necrotic tissue debris, with exposed
osteomyelitic bone at the bottom of the cavity.
Magnetic resonance imaging (MRI) excluded tumour
recurrence. She was treated with peroral
ciprofloxacine (500mg/12h) in combination with
decreasing dose scheme of prednisone (50 mg for three
days, hen reduced by 5 mg each day), and with local
itraconazol. She also underwent additional hyperbaric
oxygen therapy. Because of no improvement of her
facial palsy and an unfavourable state in the cavity, 5
months later she underwent subtotal petrosectomy in
order to explore the field and remove osteonecrotic
bone. A well vascularized temporal muscle flap and
abdominal fat was employed to obliterate the cavity.
All frozen sections were free of tumour. The
microbiological analyses revealed an invasive
infection with Aspergillus Fumigatus and treatment
with intravenous voriconazole (8mg/kg/12h) was
started. 
CT, later followed by MRI (Figure 2) examinations
were done due to headache and showed swelling of the
temporal lobe, thromboses of the transverse and
sigmoid sinuses and a hypodensity in the right
temporal lobe suspicious for an intracranial abscess.
Cerebrospinal fluid (CSF) examination was highly
suggestive of central nervous system aspergillus
infection, most likely related to the aspergillus
osteomyelitis of the lateral skull base. Besides the pre-
existent facial nerve paralysis, there were no signs of
other neurological deficits. Therefore, conservative
treatment with intravenous voriconazole (8mg/kg
every 12h) continued, monitoring its therapeutic level
(above 2mg/L) in blood and CSF [5]. Weekly MRI
scannings were done to verify the effect of treatment.
After three months the abscess showed no signs of
regression (Figure 3) and neurosurgical intervention
with drainage was performed. Histopathological and
microbiological examinations confirmed the diagnosis
neuroaspergillosis. The postoperative course was
without any complication, intravenous treatment with
voriconazole for two weeks was followed with oral
administration of the drug for more than six months.  
Five months later, she presented with a progressive
preauricular and infrauricular swelling, accompanied
by oedema of the right side of the face and neck since
three weeks. She had also lost weight and complained
of a significant decline in her physical status. MRI
showed a probable recurrence in the right parotid
gland, pterygoid fossa and the temporo-mandibular
joint regions in addition to the metastatic spread to the
regional lymph nodes in the level II verified with a fine
needle aspiration biopsy. No curative options were left
and she died in 3 months later. 
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Figure 1. Initial CT scan (June 2006), axial plane, where soft
tissue mass completely fills the right-sided external auditory canal
and extends also into the middle ear.
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Figure 2. MRI scan (T1W + flowcomp, axial and coronal plane) was taken 5 days after the subtotal petrosectomy (January 2008). The
arrows indicate the presence of an intracranial abscess.
Figure 3. Unchanged MRI scan (T1W + flowcomp, axial and coronal plane) before the neurosurgical intervention and drainage (March
2008). The arrows indicate the presence of an intracranial abscess.
Discussion
Neuroaspergillosis is a very rare disease, even in
immunocompromised patients. Low local complement
synthesis and activation may represent a central reason
for the insufficient defence in the brain of patients with
neuroaspergillosis, causing the almost 100 % mortality
of this disease [8]. Only few cases have been described
in the literature involving immunocompetent hosts [9-11]. 
Intracranial involvement by aspergillus species occurs
via haematogenous dissemination from the lungs,
extension from paranasal sinuses, or by direct
introduction at time of surgery. Haematogenous
dissemination from a pulmonary focus is the most
frequent cause of neuroaspergillosis, almost only
involving immunocompromised patients. In the
present case, pulmonary etiology was ruled out by the
chest x-ray. Extension from paranasal sinuses is a
more frequent cause in immunocompetent patients, but
seemed highly unlikely because neither physical
examination nor imaging findings showed any
evidence of paranasal sinuses disease.
In this case, the possibility of direct introduction during
surgery also seems implausible. Moreover, there was a
small CSF leak during subtotal petrosectomy for salvage
surgery, but the leak was directly plugged by periosteum,
and the time interval between surgery and MRI diagnosis
of intracranial abscess was thought to be very short (11
days) for an iatrogenic situation. In literature, the average
time between surgery and diagnosis of a postoperative
abscess was 3 months (1 to 12 months) [3]. Therefore, it is
more likely that the aspergillus invaded the central
nervous system before the time of surgery, which was also
supported by the retrospective findings on CT scan (i.e.
thrombosis of the sigmoid and transverse sinus, Figure 4). 
We suggest that the neuroaspergillosis of this patient was
caused by extension of the invasive aspergillus infection
from the temporal bone. We can hypothesise that  the
invasive effect of the SCC [12] and post-operative
radiotherapy caused a local immune attenuation which
enabled the aspergillus fumigatus to invade intracranially,
probably by a haematogenous pathway. Lateral skull base
osteomyelitis caused by aspergillus had been described in
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Figure 4. CT scan (August 2007) with contrast in the axial plane showing a thrombosis of the transverse sinus on the right site. Arrows
indicate the position of the transverse sinus, no flow is visible on the right side.
immunocompetent hosts [1] and also aspergillus infections
were reported following radiotherapy in the other parts of
the body [2]. Nevertheless, there was no reported case in
literature, where the invasive intracranial aspergillus
infection would follow the irradiation of the temporal bone
in an immunocompetent patient. 
Based on our  previous experience [13] and with the
knowledge of the clinical course in this particular case, we
optimized our therapeutic strategy for the patients who
should undergo temporal bone resection and post-
operative radiotherapy because of SCC of the temporal
bone.
In concordance with other authors [14], we consider a lateral
temporal bone resection, sometimes with parotidectomy
(superficial or total based on the T stage) and neck
dissection (if clinically positive) as the optimal treatment.
The surgery is always followed by radiotherapy in T2 and
larger tumours, and in those with perineural or vascular
invasion, positive margins or cervical metastases. The
cavity after lateral temporal bone resection needs adequate
coverage to prevent osteoradionecrosis, colonisation with
aggressive fungal and bacterial strains and potential spread
of this infection, mainly intracranially. Abdominal fat
obliteration combined with temporal muscle flap
reconstruction is considered to be the best option [15, 16]. 
Nevertheless, it is obvious that oncologic follow-up is
compromised by the obliteration technique. However,
consequent postoperative MRI scanning, in four to six
months intervals (after baseline MRI three months
postoperatively) would be an acceptable alternative. The
complete eradication of the disease in the first attempt,
including reconstruction, must be preferred because the
efficacy of the treatment of recurrent tumours is very
poor[13, 14].
Hearing is more impaired than when leaving an open
cavity, which however can be overcome by placing a bone
conduction device.
Conclusion
Key learning points of this case are that a life-threatening
disease as neuroaspergillosis can occur in an
immunocompetent host and might be related to
postoperative radiation therapy. This should always be
considered in patients with a history of irradiation of the
lateral skull base. Moreover, in patients undergoing a
temporal bone resection for SCC of the temporal bone,
obliteration of the cavity by abdominal fat and or by local
temporal muscle flap could be performed to prevent
invasive aspergillosis or other invasive fungal or bacterial
strains to colonize a cavity with the potential risk of spread
of the infection.
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